KOBILKA INSTITUTE OF INNOVATIVE DRUG DISCOVERY
Kobilka Institute of Innovative Drug Discovery and Arieh Warshel Institute of Computational Biology are the first two Nobel laureate labs at the University. These two institutes are the significant milestone in the University’s attempt to evolve into a world research university.
Professor Brian K. KOBILKA was selected as a member of the National Academy of Sciences in 2011. In 2012, due to his pioneering research work on G protein-coupled receptors, he collaborated with Professor Robert J. Lefkowitz jointly won the Nobel Prize in Chemistry. In recent years, Professor Kobilka has devoted himself to the research of structural biology of G protein-coupled receptors, and has vigorously promoted the transformation of basic achievements in related fields into drug discovery.
Over the past two years, the Kobilka Institute of Innovative Drug Discovery has attracted young talents and established a critical mass in structural biology research. And KIIDD also has its own state-of-the-art Cryo-EM Center. Aims and perspectives of KIIDD are 1. Introducing the world's top talent team in the strategic field of new medicine, obtaining innovations and breakthroughs in production, learning, research, and helping bring the world's top technology and improve the industry development in related fields in Shenzhen; 2. Carrying out basic scientific research and make sure of industrialization of biomedical technology, stimulating the development of Shenzhen into a globally important and world-leading biopharmaceutical industry base and cultivate a batch of pharmaceutical companies with international competitiveness; 3. To become an open platform for high-tech enterprise settlement and high-end technology service; 4. To vigorously promote CUHK-Shenzhen and other higher education institutions in Shenzhen to cultivate a new generation of innovative pharmaceutical research and industrialization professionals for China and Shenzhen.
More information, please scan the QR code below